As discussed on this board, since it seems difficult for a BP to value PPHM due to the huge potential upside due to many potential indications vs. the risk of buying early before many risks are eliminated why not do a deal like Roche/DNA did where BP buys a % of the whole company now. That way they get all indications and PPHM gets the money to move all indications forward.
For discussion purposes, let's say they buy 50% of the company for $1B dollars. PPHM has the money and the BP has Bavi for all indications and shareholders and the BP share in the future upside. Those shareholders who want out could get out by selling shares in the market at a price I am sure would be upwards the cash value of the company. Those that like Bavi could stay in or sell a portion of their shares
Like DNA?Roche, if all goes well BP comes back later and buys the rest at a much higher price. If Bavi and other platforms fizzle, BP isn't out as much.